Javier Jiménez-Candil1, Jesús Hernández2, Ana Martín2, José Moríñigo2, Pedro Perdiguero2, Loreto Bravo2, Sonia Ruiz2, Pedro L Sánchez2. 1. Cardiology Department, Biomedical Research Institute of Salamanca (IBSAL), University Hospital, Paseo de San Vicente, 58-182, 37007, Salamanca, Spain. jimenezcandil@secardiologia.es. 2. Cardiology Department, Biomedical Research Institute of Salamanca (IBSAL), University Hospital, Paseo de San Vicente, 58-182, 37007, Salamanca, Spain.
Abstract
PURPOSE: To determine whether monomorphic ventricular tachycardias (VTs) have different characteristics and/or responses to antitachycardia pacing (ATP) with respect to the indication-primary prevention (PP) versus secondary prevention (SP)-among ICD patients with left ventricular dysfunction. METHODS: We prospectively studied 551 VT (cycle length [CL] 329 ± 35 ms; PP 34%) occurring in 67 ICD patients with left ventricular dysfunction (LVEF 35 ± 8%). ICD programming was standardized, including ATP for slow (CL 400-321 ms) and fast VT (CL 250-320 ms). We analyzed the following aspects: CL, percentage of variability of the 12 RR intervals prior to ATP (P-RR)-which was calculated by dividing the mean difference between each R-R interval with the next one by the CL × 100-and type of termination: immediate (VT ceased immediately upon ATP completion) or delayed (VT persisted after ATP). RESULTS: ATP was successful in 86% of VTs. VTs occurring in SP patients had a lower P-RR, median (IQR) 2.7% (1.2-3.7) versus 1.9% (0.9-3.2); p = 0.002; they terminated immediately after ATP less frequently (27% versus 12%; p < 0.001), and although they were more frequently slow (51% versus 67%; p = 0.01), ATP was less effective in them, 92 versus 80% (p = 0.02). CONCLUSIONS: VTs occurring in SP patients are slower, more stable, and they terminate less frequently at ATP. Therefore, compared with PP, SP patients seem to have fewer self-terminating VTs.
PURPOSE: To determine whether monomorphic ventricular tachycardias (VTs) have different characteristics and/or responses to antitachycardia pacing (ATP) with respect to the indication-primary prevention (PP) versus secondary prevention (SP)-among ICDpatients with left ventricular dysfunction. METHODS: We prospectively studied 551 VT (cycle length [CL] 329 ± 35 ms; PP 34%) occurring in 67 ICDpatients with left ventricular dysfunction (LVEF 35 ± 8%). ICD programming was standardized, including ATP for slow (CL 400-321 ms) and fast VT (CL 250-320 ms). We analyzed the following aspects: CL, percentage of variability of the 12 RR intervals prior to ATP (P-RR)-which was calculated by dividing the mean difference between each R-R interval with the next one by the CL × 100-and type of termination: immediate (VT ceased immediately upon ATP completion) or delayed (VT persisted after ATP). RESULTS:ATP was successful in 86% of VTs. VTs occurring in SP patients had a lower P-RR, median (IQR) 2.7% (1.2-3.7) versus 1.9% (0.9-3.2); p = 0.002; they terminated immediately after ATP less frequently (27% versus 12%; p < 0.001), and although they were more frequently slow (51% versus 67%; p = 0.01), ATP was less effective in them, 92 versus 80% (p = 0.02). CONCLUSIONS: VTs occurring in SP patients are slower, more stable, and they terminate less frequently at ATP. Therefore, compared with PP, SP patients seem to have fewer self-terminating VTs.
Authors: Etienne M Aliot; William G Stevenson; Jesus Ma Almendral-Garrote; Frank Bogun; C Hugh Calkins; Etienne Delacretaz; Paolo Della Bella; Gerhard Hindricks; Pierre Jaïs; Mark E Josephson; Josef Kautzner; G Neal Kay; Karl-Heinz Kuck; Bruce B Lerman; Francis Marchlinski; Vivek Reddy; Martin-Jan Schalij; Richard Schilling; Kyoko Soejima; David Wilber Journal: Europace Date: 2009-05-14 Impact factor: 5.214
Authors: Javier Jiménez-Candil; Ignasi Anguera; Claudio Ledesma; Javier Fernández-Portales; José Luis Moríñigo; Paolo Dallaglio; Ana Martín; Teresa Cano; Jesús Hernández; Xavier Sabaté; Cándido Martín-Luengo Journal: J Cardiovasc Electrophysiol Date: 2013-09-09
Authors: Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews Journal: N Engl J Med Date: 2002-03-19 Impact factor: 91.245
Authors: James P Daubert; Wojciech Zareba; David S Cannom; Scott McNitt; Spencer Z Rosero; Paul Wang; Claudio Schuger; Jonathan S Steinberg; Steven L Higgins; David J Wilber; Helmut Klein; Mark L Andrews; W Jackson Hall; Arthur J Moss Journal: J Am Coll Cardiol Date: 2008-04-08 Impact factor: 24.094
Authors: Javier Jiménez-Candil; Olga Durán; Jean Núñez; Loreto Bravo; Jesús Hernández; Ana Martín-García; José Morínigo; Pedro L Sánchez Journal: J Interv Card Electrophysiol Date: 2019-09-16 Impact factor: 1.900